UCSF University of California, San Francisco
About UCSF
UCSF Children's Hospital
Search

Welcome

Hospitals and Clinics

Appointments

Billing

Directions

Gift Shops

Health Insurance

Medical Records

Patient Mail

Phone Numbers

Visiting Hours

...and more

Doctor Directory

Appointments

Health Insurance

Overview

A-Z Conditions

Arthritis

Bone Marrow Transplant

Cancer

Children's Services

Clinical Laboratories

Heart Care

Hormonal Disorders

Memory Disorders

Neurological Disorders

Organ Transplants

Orthopedics

Primary Care

Radiology

Women's Health

...and more

Overview

Clinical Trials

Conditions

Events and Classes

Medical Dictionary

Medical Tests

News

Patient Education

Publications

Research

Specialized Services

Other Resources

Overview

Billing

Clinical Trials

Consultations

Continuing Education

Health Insurance

News

Outreach Clinics

Publications

Referrals

Transfers

UCSF Medical Group

Patient Guide Find a Doctor Medical Services Health Library For Health Professionals

UCSF Launches New Phase of Brain Tumor Vaccine Trial
The UCSF Brain Tumor Research Center initiated a Phase 2 clinical trial of a vaccine to treat glioma. The trial will evaluate survival in patients receiving vitespen vaccination, trademarked as Oncophage.

Neurosurgeon Named to Two National Organizations
Dr. Mitch Berger, UCSF chair of Neurological Surgery, was elected to the board of the American Association of Neurological Surgeons and appointed to the American Board of Neurological Surgeons.

FALL 2007

Deep Brain Stimulation for Dystonia

Dystonia is a syndrome of sustained muscle contractions that produce writhing movements and abnormal posturing. Primary dystonia occurs without any other neurological conditions. Dystonia is thought to be due to abnormal signal processing in the basal ganglia, part of the brain’s motor control system.

A number of medical therapies are used to treat dystonias, but all have limitations. Anticholinergic medications, benzodiazapines and baclofen have all shown clinical benefit. For focal dystonia, denervation with botulinum toxins can be helpful. However, for severe generalized dystonia, these therapies are often only partially effective or cause intolerable side effects.

Recently, chronic deep brain electrical stimulation (DBS) of the globus pallidus, a brain structure that receives the major portion of the output of the basal ganglia, has been shown to be an effective treatment for appropriately chosen patients with generalized dystonia. At this time, there is no clear understanding of the mechanism by which DBS affects dystonia and no full understanding of the physiological action of the globus pallidus in dystonia.

However, empirical evidence has shown that DBS can be highly effective in therapy for the disorder. In patients without fixed skeletal deformities, this procedure is associated with at least a 50 percent improvement in standardized rating scales of dystonia severity one year after surgery.

UCSF Medical Center has the busiest program of surgery for movement disorders in the western United States and is a pioneer in DBS surgery for the treatment of dystonia. The UCSF program utilizes an integrated team of neurologists, neurosurgeons and nurses who specialize in movement disorders surgery. This full-service, multidisciplinary program coordinates care so that patients can be seen by various specialists on the same day.

For more information, call Jill Ostrem, M.D., at (415) 353-2273 or Phillip Starr, M.D., at (415) 353-7500.

        

Neuroscience — Fall 2007 Table of Contents

Click here to subscribe to this newsletter.

          

Home | About the Medical Center | Contact Us | Jobs | Compliance / Hotline
Copyright © 2002 - 2009 The Regents of the University of California | Terms of Use | Site Map